COM:NEUROPACE
NeuroPace
- Stock
Last Close
9.00
22/11 21:00
Market Cap
197.64M
Beta: -
Volume Today
66.64K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 7.40M - | 7.37M 0.53% | 8.77M 19.03% | 10.46M 19.35% | ||
average payables | 926K - | 1.16M 25.65% | 1.76M 51.48% | 2.24M 27.06% | ||
average receivables | 7.21M - | 7.74M 7.45% | 7.29M 5.90% | 9.90M 35.84% | ||
book value per share | -11.65 - | -13.31 14.29% | 4.43 133.24% | 1.41 68.05% | 0.00 99.94% | |
capex per share | -0.04 - | -0.01 86.75% | -0.02 314.05% | -0.02 6.04% | ||
capex to depreciation | -1.11 - | -0.20 82.12% | -1.30 552.83% | -0.20 84.44% | ||
capex to operating cash flow | 0.02 - | 0.00 84.66% | 0.02 444.56% | 0.02 4.68% | ||
capex to revenue | -0.01 - | -0.00 88.09% | -0.01 463.91% | -0.01 55.87% | ||
cash per share | 0.46 - | 3.43 647.82% | 6.96 102.92% | 3.15 54.77% | 0.00 99.92% | |
days of inventory on hand | 274.41 - | 232.08 15.43% | 243.02 4.71% | 272.12 11.97% | 236.61 13.05% | |
days payables outstanding | 31.37 - | 31.88 1.63% | 42.81 34.30% | 60.16 40.51% | 49.20 18.21% | |
days sales outstanding | 59.40 - | 74.49 25.39% | 57.28 23.09% | 59.99 4.73% | 68.70 14.52% | |
debt to assets | 2.98 - | 0.94 68.26% | 0.37 60.50% | 0.61 63.83% | 0.67 9.99% | |
debt to equity | -0.49 - | -0.36 26.34% | 0.68 289.65% | 2.01 195.82% | 3.51 74.72% | |
dividend yield | ||||||
earnings yield | -0.15 - | -0.13 11.68% | -0.23 75.32% | -1.46 539.79% | -0.00 99.99% | |
enterprise value | 335.82M - | 303.61M 9.59% | 198.08M 34.76% | 99.81M 49.61% | 266.59B 266,996.07% | |
enterprise value over ebitda | -16.73 - | -24.33 45.37% | -6.98 71.30% | -2.52 63.85% | -9.81K 388,670.55% | |
ev to operating cash flow | -13.42 - | -14.05 4.71% | -8.06 42.64% | -2.71 66.41% | -13.53K 499,751.03% | |
ev to sales | 9.08 - | 7.38 18.75% | 4.38 40.60% | 2.19 49.98% | 4.07K 185,745.73% | |
free cash flow per share | -2.30 - | -1.95 15.00% | -1.50 23.00% | -1.52 1.38% | -0.00 99.95% | |
free cash flow yield | -0.09 - | -0.08 15.00% | -0.15 90.67% | -1.02 585.83% | -0.00 99.99% | |
graham net net | -12.33 - | -14.05 13.93% | 3.90 127.76% | 0.35 91.09% | -0.00 100.06% | |
graham number | 31.01 - | 31.16 0.47% | 15.12 51.49% | 8.31 45.03% | 0.00 99.94% | |
income quality | 0.83 - | 0.89 6.60% | 0.68 23.47% | 0.78 14.96% | 0.60 23.66% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -2.32 - | -1.14 51.08% | -3.20 181.92% | -5.42 69.14% | 3.19 158.89% | |
interest debt per share | 6.51 - | 5.80 10.98% | 3.45 40.52% | 3.14 8.83% | 0.00 99.92% | |
inventory turnover | 1.33 - | 1.57 18.24% | 1.50 4.50% | 1.34 10.69% | 1.54 15.01% | |
invested capital | -0.49 - | -0.36 26.34% | 0.68 289.65% | 2.01 195.82% | 3.51 74.72% | |
market cap | 277.14M - | 277.14M 0% | 167.42M 39.59% | 36.65M 78.11% | 266.53B 727,211.39% | |
net current asset value | -130.19M - | -149.22M 14.62% | 72.76M 148.76% | 18.39M 74.73% | 5.72M 68.88% | |
net debt to ebitda | -2.92 - | -2.12 27.45% | -1.08 49.06% | -1.60 47.79% | -2.00 25.22% | |
net income per share | -3.67 - | -3.24 11.68% | -2.29 29.20% | -2.17 5.43% | -0.00 99.94% | |
operating cash flow per share | -2.25 - | -1.95 13.65% | -1.48 23.97% | -1.50 1.30% | -0.00 99.95% | |
payables turnover | 11.64 - | 11.45 1.61% | 8.53 25.54% | 6.07 28.83% | 7.42 22.26% | |
receivables turnover | 6.14 - | 4.90 20.25% | 6.37 30.03% | 6.08 4.52% | 5.31 12.68% | |
research and ddevelopement to revenue | 0.49 - | 0.38 22.90% | 0.40 5.64% | 0.48 19.62% | 0.32 34.12% | |
return on tangible assets | -1.93 - | -0.64 66.70% | -0.29 55.63% | -0.47 63.92% | -0.31 34.55% | |
revenue per share | 3.33 - | 3.71 11.27% | 2.72 26.57% | 1.85 31.97% | 0.00 99.86% | |
roe | 0.31 - | 0.24 22.72% | -0.52 313.01% | -1.53 195.99% | -1.60 3.97% | |
roic | 0.45 - | 0.20 54.73% | -0.20 199.80% | -0.38 87.40% | -0.25 34.24% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | -11.65 - | -13.31 14.29% | 4.43 133.24% | 1.41 68.05% | 0.00 99.94% | |
stock based compensation to revenue | 0.04 - | 0.03 14.05% | 0.09 183.11% | 0.18 93.26% | 0.15 20.34% | |
tangible asset value | -129.35M - | -147.83M 14.29% | 73.50M 149.72% | 34.78M 52.69% | 20.65M 40.61% | |
tangible book value per share | -11.65 - | -13.31 14.29% | 4.43 133.24% | 1.41 68.05% | 0.00 99.94% | |
working capital | -54.89M - | 44.97M 181.93% | 123.52M 174.68% | 86.74M 29.78% | 76.49M 11.81% |
All numbers in (except ratios and percentages)